Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report

Cited by (1,000)

Items 801–900 of 1,000

1. Emotional Reactions to Music in Dementia Patients and Healthy Controls: Differential Responding Depends on the Mechanism
   Gonçalo T. Barradas, Patrik N. Juslin, Sergi Bermúdez i Badia · 2021 · Music & Science
2. Alzheimer’s disease is an inherent, natural part of human brain aging: an integrated perspective
   Isidró Ferrer · 2022 · Free Neuropathology
3. The Advancements of Marine Natural Products in the Treatment of Alzheimer’s Disease: A Study Based on Cell and Animal Experiments
   Chunbo Jia, Jiaxin Chai, Shenyun Zhang, Yining Sun, Liheng He, Zhipei Sang, Dapeng Chen, Xu Zheng · 2025 · Marine Drugs
4. Antibodies bound to Aβ oligomers potentiate the neurotoxicity of Aβ by activating microglia
   Ramunė Morkūnienė, Aurelija Žvirblienė, Indrė Dalgėdienė, Paulius Čižas, Silvija Jankevičiūtė, Giedrė Baliūtytė, Ramūnas Jokubka, Marija Jankunec, Gintaras Valinčius, Vilmantė Borutaitė · 2013 · Journal of Neurochemistry
5. Familial Presenilin Mutations and Sporadic Alzheimer’s Disease Pathology: Is the Assumption of Biochemical Equivalence Justified?
   Alex E. Roher, Chera L. Maarouf, Tyler A. Kokjohn · 2016 · Journal of Alzheimer s Disease
6. Current Management and Therapeutic Strategies for Cerebral Amyloid Angiopathy
   Yasuteru Inoue, Yukio Ando, Yohei Misumi, Mitsuharu Ueda · 2021 · International Journal of Molecular Sciences
7. In vivo target validation using gene invalidation, RNA interference and protein functional knockout models: it is the time to combine
   Olivier Vidalin, Machadiya Muslmani, Clément Estienne, Hamid Echchakir, Amine M. Abina · 2009 · Current Opinion in Pharmacology
8. Present and prospective clinical therapeutic regimens for Alzheimer’s disease
   Mustafa M. Husain · 2008 · Neuropsychiatric Disease and Treatment
9. Engineered Proteolytic Nanobodies Reduce Aβ Burden and Ameliorate Aβ-Induced Cytotoxicity
   Srinath Kasturirangan, Shanta P. Boddapati, Michael R. Sierks · 2010 · Biochemistry
10. Fibrillar and Oligomeric β‐Amyloid as Distinct Local Biomarkers for Alzheimer's Disease
    Michael Montalto, Gill Farrar, Cristina A. Tan Hehir · 2007 · Annals of the New York Academy of Sciences
11. Setback for an Alzheimer’s disease vaccine
    Paul M. Mathews, Ralph A. Nixon · 2003 · Neurology
12. Alzheimer's Disease
    Alan M. Mandell, Robert C. Green · 2011 · Wiley eBooks
13. Histopathological correlates of haemorrhagic lesions on ex vivo magnetic resonance imaging in immunized Alzheimer’s disease cases
    Ashley A. Scherlek, Mariel G. Kozberg, James A. R. Nicoll, Valentina Perosa, Whitney M. Freeze, Louise van der Weerd, Brian J. Bacskai, Steven Mark Greenberg, Matthew P. Frosch, Delphine Boche et al. · 2022 · Brain Communications
14. Harnessing the Immune System for Treatment and Detection of Tau Pathology
    Erin E. Congdon, Senthilkumar Krishnaswamy, Einar M. Sigurdsson · 2014 · Journal of Alzheimer s Disease
15. The combined treatment of amyloid-β1-42-stimulated bone marrow–derived dendritic cells plus splenocytes from young mice prevents the development of Alzheimer's disease in APPswe/PSENldE9 mice
    Fei Wang, Hanqiu Liu, Xueyan Shen, Hong Ao, Nick Moore, Lingling Gao, Long Chen, Heng Hu, Huiying Ma, Zixiao Yang et al. · 2014 · Neurobiology of Aging
16. IgA antibodies of coeliac disease patients recognise a dominant T cell epitope of Α-gliadin
    Elizabeth A. L. Bateman, B L Ferry, A Hall, S A Misbah, R Anderson, P Kelleher · 2004 · Gut
17. Development, Optimization and Use of Preclinical Behavioral Models to Maximize the Productivity of Drug Discovery for Alzheimer's Disease
    Mark D. Lindner, Robert Albert McArthur, Sam A. Deadwyler, Robert E. Hampson, Pierre N. Tariot · 2008 · Elsevier eBooks
18. Discovery of a Small Molecule that Enhances Astrocytogenesis by Activation of STAT3, SMAD1/5/8, and ERK1/2 via Induction of Cytokines in Neural Stem Cells
    Ha‐Rim Lee, Farhanullah, JiSoo Lee, Rahul Jajoo, Sun-Young Kong, Jae-Yeon Shin, Jae‐Ouk Kim, Jeewoo Lee, Jeewoo Lee, Hyun‐Jung Kim · 2015 · ACS Chemical Neuroscience
19. Early active immunization with Aβ 3–10 -KLH vaccine reduces tau phosphorylation in the hippocampus and protects cognition of mice
    Yunpeng Cao, Jin-Chun Wang, Kun Zhu, Huiyi Zhang, Guoqing Wang, Huiying Liu · 2019 · Neural Regeneration Research
20. A generic class of amyloid fibril inhibitors
    Sian‐Yang Ow, Innocent B. Bekard, Anton Blencowe, Greg GuangHua Qiao, Dave E. Dunstan · 2014 · Journal of Materials Chemistry B
21. A Comparative Evaluation of a Novel Vaccine in APP/PS1 Mouse Models of Alzheimer’s Disease
    Iván Carrera, Ignacio Etcheverrı́a, L. Fernández‐Novoa, Valter Lombardi, Madepalli Krishnappa Lakshmana, Ramón Cacabelos, Carmen Vigo · 2015 · BioMed Research International
22. Evaluation of a DNA Aβ42 vaccine in adult rhesus monkeys (Macaca mulatta): antibody kinetics and immune profile after intradermal immunization with full-length DNA Aβ42 trimer
    Doris Lambracht‐Washington, Min Fu, Pat Frost, Roger N. Rosenberg · 2017 · Alzheimer s Research & Therapy
23. The Amyloid Hypothesis and the clearance and degradation of Alzheimer's β-peptide
    Harry LeVine · 2004 · Journal of Alzheimer s Disease
24. Immunization with amyloid-β using GM-CSF and IL-4 reduces amyloid burden and alters plaque morphology
    Kevin Da Silva, Mary E. Brown, David A. Westaway, JoAnne McLaurin · 2006 · Neurobiology of Disease
25. Epitope structure and binding affinity of single chain llama anti‐β‐amyloid antibodies revealed by proteolytic excision affinity‐mass spectrometry
    Gabriela Paraschiv, Cécile Vincke, Paulina Czaplewska, Marilena Manea, Serge Muyldermans, Michael Przybylski · 2012 · Journal of Molecular Recognition
26. Experimental Models of HD and Reflection on Therapeutic Strategies
    Jinho Kim, Olivia L. Bordiuk, Robert J. Ferrante · 2011 · International review of neurobiology
27. Effect of amyloid‐β ( A β) immunization on hyperphosphorylated tau: a potential role for glycogen synthase kinase (GSK )‐3β
    Jay Amin, Claire Paquet, Alex Baker, Ayodeji A. Asuni, Seth Love, Clive Holmes, Jacques Hugon, James A. R. Nicoll, Delphine Boche · 2014 · Neuropathology and Applied Neurobiology
28. Reduction of amyloid β-peptide accumulation in Tg2576 transgenic mice by oral vaccination
    Rika Ishii-Katsuno, Akiko Nakajima, Taro Katsuno, Jun Nojima, Eugene Futai, Noboru Sasagawa, Taiji Yoshida, Yuichiro Watanabe, Shoichi Ishiura · 2010 · Biochemical and Biophysical Research Communications
29. Transport of cargo from periphery to brain by circulating monocytes
    Amarallys F. Cintron, Nirjari V. Dalal, Jeromy M. Dooyema, Ranjita S. Betarbet, Lary C. Walker · 2015 · Brain Research
30. Vaccine-induced Aβ-specific CD8+ T cells do not trigger autoimmune neuroinflammation in a murine model of Alzheimer’s disease
    M. Bruley-Rosset, Gabrielle Lui, Cira Dansokho, Thomas Chaigneau, Guillaume Dorothée · 2015 · Journal of Neuroinflammation
31. Therapeutic Vaccines for Hypertension and Dyslipidemia
    Hironori Nakagami, Hiroshi Koriyama, Ryuichi Morishita · 2014 · International Heart Journal
32. Preventing Alzheimer’s Disease
    Mary Sano, Hillel T. Grossman, Kathleen Van Dyk · 2008 · CNS Drugs
33. Immunization with fibrillar Aβ1–42 in young and aged canines: Antibody generation and characteristics, and effects on CSF and brain Aβ
    Elizabeth Head, Edward G. Barrett, Michael Paul Murphy, Pritam Das, Mihaela Nistor, Floyd M. Sarsoza, Charles C. Glabe, Rakez Kayed, Saskia C. F. Milton, Vitaly Vasilevko · 2006 · Vaccine
34. A 63-year-old man with headaches and behavioral deterioration
    Steven Mark Greenberg, Joseph E. Parisi, B. Mark Keegan · 2007 · Neurology
35. Chaperone-Like Antibodies in Neurodegenerative Tauopathies: Implication for Immunotherapy
    Eva Kontseková, Natalia Paulenka Ivanovova, Martina Handzusova, Michal Novák · 2009 · Cellular and Molecular Neurobiology
36. Therapeutic Vaccines against Human and Rat Renin in Spontaneously Hypertensive Rats
    Zhihua Qiu, Xiao Chen, Yanzhao Zhou, Jibin Lin, Dan Ding, Shijun Yang, Fen Chen, Min Wang, Feng Zhu, Xianjun Yu et al. · 2013 · PLoS ONE
37. Vascular consequences of passive Aβ immunization for Alzheimer's disease. Is avoidance of "malactivation" of microglia enough?
    Steven W. Barger · 2005 · Journal of Neuroinflammation
38. Differences in the immune response to long term A? vaccination in C57BL/6 and B6D2F1 mice
    Timothy J. Seabrook · 2004 · Vaccine
39. Therapeutic Advances in Targeting the Amyloid-β Pathway for Alzheimer’s Disease
    Beiyu Zhang, Yunan Li, Huan Li, Xiaoxia Shen, Zheying Zhu · 2025 · Brain Sciences
40. Vaccines for prion diseases: a realistic goal?
    Scott Napper, Hermann M. Schätzl · 2023 · Cell and Tissue Research
41. Targets, trials and tribulations in Alzheimer therapeutics
    Ruchita Gharat, Gargi Dixit, Mihir Khambete, Arati Prabhu · 2023 · European Journal of Pharmacology
42. Immunocytochemical Characterization of Alzheimer Disease Hallmarks in APP/PS1 Transgenic Mice Treated with a New Anti-Amyloid-βVaccine
    Iván Carrera, Ignacio Etcheverrı́a, Yi Li, L. Fernández‐Novoa, Valter Lombardi, Carmen Vigo, Hector H. Palacios, Valery V. Benberin, Ramón Cacabelos, Gjumrakch Aliev · 2013 · BioMed Research International
43. Successful adjuvant-free vaccination of BALB/c mice with mutated amyloid β peptides
    Chuanhai Cao, Xiaoyang Lin, Monika Maya Wahi, Eugene A. Jackson, Huntington Potter · 2008 · BMC Neuroscience
44. Pharmacological properties of a novel and potent γ-secretase modulator as a therapeutic option for the treatment of Alzheimer’s disease
    Koji Murakami, Tomomichi Watanabe, Tatsuki Koike, Makoto Kamata, Tomoko Igari, Shinichi Kondo · 2015 · Brain Research
45. Comparison of Efficacy of Preventive and Therapeutic Vaccines Targeting the N Terminus of β-Amyloid in an Animal Model of Alzheimer’s Disease
    Irina Petrushina, Hayk Davtyan, Armine Hovakimyan, Arpine Davtyan, Giselle Fazzioni Passos, David H. Cribbs, Anahit Ghochikyan, Michael G. Agadjanyan · 2017 · Molecular Therapy
46. Experimental approaches for altering the expression of Abeta‐degrading enzymes
    David A. Loeffler · 2023 · Journal of Neurochemistry
47. Alzheimer's disease and related dementias
    John Hardy · 2012 · Cambridge University Press eBooks
48. Virus-like Peptide Vaccines Against Aß N-terminal or C-Terminal Domains Reduce Amyloid Deposition in APP Transgenic Mice without Addition of Adjuvant
    Qing-you Li, Marcia N. Gordon, Bryce Chackerian, Jennifer Alamed, Kenneth E. Ugen, David Morgan · 2010 · Journal of Neuroimmune Pharmacology
49. The Amyloid β Protein
    Noel D. Lazo, Samir Kumar Maji, Erica A. Fradinger, Gal Bitan, David B. Teplow · 2005 · Wiley eBooks
50. T cell mediated cerebral hemorrhages and microhemorrhages during passive Aβ immunization in APPPS1 transgenic mice
    Melanie Meyer‐Luehmann, J. Rodrigo Mora, Matthew L. Mielke, Tara L. Spires‐Jones, Alix de Calignon, Ulrich H. von Andrian, Bradley T. Hyman · 2011 · Molecular Neurodegeneration
51. The immunological potency and therapeutic potential of a prototype dual vaccine against influenza and Alzheimer's disease
    Hayk Davtyan, Anahit Ghochikyan, Richard Cadagan, Dmitriy Zamarin, Irina Petrushina, Nina Movsesyan, Luis Martínez‐Sobrido, Randy A. Albrecht, Adolfo García‐Sastre, Michael G. Agadjanyan · 2011 · Journal of Translational Medicine
52. Neuroimmune interactions in Alzheimer's disease—New frontier with old challenges?
    Stefan Prokop, Virginia M.‐Y. Lee, John Q. Trojanowski · 2019 · Progress in molecular biology and translational science
53. Pharmakologische Therapie der Alzheimer-Demenz
    Patrick Müller, Markus Fendt, N. Müller · 2019 · Der Internist
54. Engineered hepatitis B core virus-like particle carrier for precise and personalized Alzheimer’s disease vaccine preparation via fixed-point coupling
    Mei Ji, Xi-xiu Xie, Dong‐qun Liu, Shuai Lü, Lingxiao Louis Zhang, Yaru Huang, Rui‐tian Liu · 2020 · Applied Materials Today
55. Mutant Amyloid-beta-sensitized dendritic cells as Alzheimer's disease vaccine
    Chuanhai Cao, Xiaoyang Lin, Chi Zhang, Monika Maya Wahi, Inge Wefes, Gary W. Arendash, Huntington Potter · 2008 · Journal of Neuroimmunology
56. Identification of the shortest Aβ-peptide generating highly specific antibodies against the C-terminal end of amyloid-β42
    Trine V. Axelsen, Arne Holm, Gunna Christiansen, Svend Birkelund · 2011 · Vaccine
57. Current Experimental Therapy for Alzheimers Disease
    Sheng Chen, Xiao-Jie Zhang, Liang Li, Wei-Dong Le · 2007 · Current Neuropharmacology
58. New pathways in drug discovery for alzheimer’s disease
    Eric Siemers, Robert A. Dean, Ronald Bradley Demattos, Patrick C. May · 2006 · Current Neurology and Neuroscience Reports
59. Enhanced Th2 immunity after DNA prime–protein boost immunization with amyloid β (1–42) plus CpG oligodeoxynucleotides in aged rats
    Sarada Subramanian, Akshi Shree · 2008 · Neuroscience Letters
60. DNA Vaccine Therapy for Alzheimer's Disease: Present Status and Future Direction
    Yoshio Okura, Yoh Matsumoto · 2008 · Rejuvenation Research
61. Biomarkers of Alzheimer disease in plasma
    Michael C. Irizarry · 2004 · Neurotherapeutics
62. Active immunization trial in Aβ42-injected P301L tau transgenic mice
    Luka Kulic, Pascal Kurosinski, Feng Chen, Jay Tracy, M. Hasan Mohajeri, Hong Li, Roger M. Nitsch, Jürgen Götz · 2005 · Neurobiology of Disease
63. Failure, Success, and Future Direction of Alzheimer Drugs Targeting Amyloid‐β Cascade: Pros and Cons of Chemical and Biological Modalities
    Jimin Kim, Hanna Jeon, Hye Yun Kim, Young Soo Kim · 2023 · ChemBioChem
64. “No screams and cries will convince us that white is white and black is black”, an ode to the defenders of amyloid cascade hypothesis of Alzheimer's disease
    Marek Łuczkowski · 2016 · Coordination Chemistry Reviews
65. Overview and Current Status of Alzheimer’s Disease in Bangladesh
    Md. Rashidur Rahman, Afsana Tajmim, Mohammad Ali, Mostakim Sharif · 2017 · Journal of Alzheimer s Disease Reports
66. Amyloids in Site-Specific Autoimmune Reactions and Inflammatory Responses
    Yanmei Huang, Xuezhi Hong, Jian Xing Shen, Li-Jun Geng, Yan-Hong Pan, Wei Ling, Hai‐Lu Zhao · 2020 · Frontiers in Immunology
67. Yeast-Based Aβ1-15 Vaccine Elicits Strong Immunogenicity and Attenuates Neuropathology and Cognitive Deficits in Alzheimer’s Disease Transgenic Mice
    Dong‐qun Liu, Shuai Lü, Lun Zhang, Yaru Huang, Mei Ji, Xiaoying Sun, Xiaoge Liu, Rui‐tian Liu · 2020 · Vaccines
68. Antibody Fragments as Tools for Elucidating Structure-Toxicity Relationships and for Diagnostic/Therapeutic Targeting of Neurotoxic Amyloid Oligomers
    Andre L.B. Bitencourt, Raquel Maria de Campos, Erika N. Cline, William L. Klein, Adriano Silva Sebollela · 2020 · International Journal of Molecular Sciences
69. The Development of Pharmacological Therapies for Alzheimer’s Disease
    Lin Ping, Junyu Sun, Qi Cheng, Yue Yang, Dennis John Cordato, Jianqun Gao · 2021 · Neurology and Therapy
70. Alzheimer's disease clinical trials: past failures and future opportunities
    Roy Yaari, Ann Marie Hake · 2015 · Clinical Investigation
71. Opposite patterns of age-associated changes in neurons and glial cells of the thalamus of human brain
    Diego Guidolin, Elena Zunarelli, Susanna Genedani, G. P. Trentini, C. De Gaetani, Kjell Fuxé, C. Benegiamo, L.F. Agnati · 2007 · Neurobiology of Aging
72. Secretases as therapeutic targets in Alzheimer’s disease: patents 2000 – 2004
    Andrew J. Larner · 2004 · Expert Opinion on Therapeutic Patents
73. Amyloid-β Immunotherapies in Mice and Men
    Robert P. Brendza, David M. Holtzman · 2006 · Alzheimer Disease & Associated Disorders
74. Translational considerations for CNS gene therapy
    Deborah A. Ryan, Howard J. Federoff · 2007 · Expert Opinion on Biological Therapy
75. Antibody against C-terminal Abeta selectively elevates plasma Abeta
    Audrey J. Gray, Gaku Sakaguchi, Chiharu Shiratori, Amanda G. Becker, John J. LaFrancois, Paul S. S. Aisen, Karen Duff, Yasuji Matsuoka · 2007 · Neuroreport
76. Immunotherapy for Alzheimer's Disease
    Patrick L. McGeer, Edith G. McGeer · 2004 · Science of Aging Knowledge Environment
77. Passive Anti-amyloid Beta Monoclonal Antibodies: Lessons Learned over Past 20 Years
    Alexandra Wicker, Jahnavi Shriram, Boris Decourt, Marwan Noel Sabbagh · 2024 · Neurology and Therapy
78. Therapeutic Potential of Vaccines for Alzheimer‘s Disease
    Salim Shah, Howard J. Federoff · 2011 · Immunotherapy
79. Women with the Alzheimer’s risk marker ApoE4 lose Aβ-specific CD4+ T cells 10–20 years before men
    Aynun Nahar Begum, Celia Da Cunha, Harpreet Sidhu, Tursun Alkam, J Scolnick, Emily Rose Rosario, Douglas W. Ethell · 2014 · Translational Psychiatry
80. Intranasal inoculation with an adenovirus vaccine encoding ten repeats of Aβ3-10 reduces AD-like pathology and cognitive impairment in Tg-APPswe/PSEN1dE9 mice
    Yu Li, Ying Ma, Lixia Zong, Xiaona Xing, Rong Guo, Tongzi Jiang, Sha Sha, Li Liu, Yunpeng Cao · 2012 · Journal of Neuroimmunology
81. Oral Administration of a Fusion Protein between the Cholera Toxin B Subunit and the 42-Amino Acid Isoform of Amyloid-β Peptide Produced in Silkworm Pupae Protects against Alzheimer's Disease in Mice
    Si Li, Zhen Wei, Jian Chen, Yanhong Chen, Zhengbing Lv, Wei Yu, Qiaohong Meng, Yongfeng Jin · 2014 · PLoS ONE
82. Consent in Alzheimer's Disease Research: Risk/Benefit Factors
    B. Lynn Beattie · 2007 · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
83. La maladie d’Alzheimer : des lésions cérébrales aux perspectives thérapeutiques
    Françoise Forette, Françoise Forette · 2008 · Bulletin de l Académie Nationale de Médecine
84. Investigation of the Structure of Full-Length Tau Proteins with Coarse-Grained and All-Atom Molecular Dynamics Simulations
    Xibing He, Viet Hoang Man, Jie Gao, Junmei Wang · 2022 · ACS Chemical Neuroscience
85. Impact of amyloid β aggregate maturation on antibody treatment in APP23 mice
    Karthikeyan Balakrishnan, Ajeet Rijal Upadhaya, Julia L. Steinmetz, Julia Reichwald, Dorothée Abramowski, Marcus Fändrich, Sathish Kumar, Haruyasu Yamaguchi, Jochen Walter, Matthias Staufenbiel et al. · 2015 · Acta Neuropathologica Communications
86. Detection and Control of Prion Diseases in Food Animals
    Peter D. Hedlin, Ryan Taschuk, Andrew A. Potter, Philip John Griebel, Scott Napper · 2012 · ISRN Veterinary Science
87. Promoting α‐secretase cleavage of beta‐amyloid with engineered proteolytic antibody fragments
    Srinath Kasturirangan, Dan Brune, Michael R. Sierks · 2009 · Biotechnology Progress
88. Diminished Amyloid-β Burden in Tg2576 Mice Following a Prophylactic Oral Immunization with a Salmonella-Based Amyloid-β Derivative Vaccine
    Allal Boutajangout, Fernando Goñi, Elin Knudsen, Fernanda Schreiber, Ayodeji A. Asuni, David Quartermain, Blas Frangione, Alejandro Chabalgoity, Thomas Wısnıewskı, Einar M. Sigurdsson · 2009 · Journal of Alzheimer s Disease
89. Conditionally inducible tau mice – designing a better mouse model of neurodegenerative diseases
    Christopher Janus · 2008 · Genes Brain & Behavior
90. Depressive symptoms and cognitive decline--disentangling the effect of affect
    Robert J. Stewart · 2004 · Journal of Neurology Neurosurgery & Psychiatry
91. A critical overview of therapeutic strategy and advancement for Alzheimer's disease treatment
    Yung‐Chih Kuo, Rajendiran Rajesh · 2017 · Journal of the Taiwan Institute of Chemical Engineers
92. Nonviral DNA Vaccination Augments Microglial Phagocytosis of β-Amyloid Deposits as a Major Clearance Pathway in an Alzheimer Disease Mouse Model
    Yoshio Okura, Kuniko Kohyama, Il-Kwon Park, Yoh Matsumoto · 2008 · Journal of Neuropathology & Experimental Neurology
93. Intracerebroventricular passive immunization in transgenic mouse models of Alzheimer’s disease
    Neelima B. Chauhan, George J. Siegel · 2004 · Expert Review of Vaccines
94. Mild Cognitive Impairment
    2006 · Wiley eBooks
95. AD Vaccines: Conclusions and Future Directions
    Wisniewski, Thomas · 2009 · CNS & Neurological Disorders - Drug Targets
96. Enhanced Aβ1–40 Production in Endothelial Cells Stimulated with Fibrillar Aβ1–42
    Jayakumar Rajadas, Wenchao Sun, Hai Li, Mohammed Inayathullah, Damiano M. Cereghetti, Aaron Tan, Valéria de Mello Coelho, Francis J. Chrest, John W. Kusiak, Wanli Wei Smith et al. · 2013 · PLoS ONE
97. Alzheimer's disease: is a vaccine possible?
    Rúbens Prince dos Santos Alves, Min Yang, Milene Tavares Batista, Luís Carlos de Souza Ferreira · 2014 · Brazilian Journal of Medical and Biological Research
98. Is Alzheimer disease a failure of mobilizing immune defense? Lessons from cognitively fit oldest-old
    Pavel Katsel, Vahram H. Haroutunian · 2019 · Phlebolymphology
99. Aberrant accentuation of neurofibrillary degeneration in the hippocampus of Alzheimer's disease with amyloid precursor protein 717 and presenilin-1 gene mutations
    Satoru Sudo, Masaki Shiozawa, Nigel J. Cairns, Yuji Wada · 2005 · Journal of the Neurological Sciences
100. Therapeutic removal of amyloid deposits in cutaneous amyloidosis by localised intra‐lesional injections of anti‐amyloid antibodies
     Audra L. Clos, Cristian A. Lasagna‐Reeves, Richard F. Wagner, Brent C Kelly, George R. Jackson, Rakez Kayed · 2010 · Experimental Dermatology